NT-I7 maintains cancer-specific T-cell amplifying efficacy when combined with standard of care colorectal cancer therapy FOLFOX ® Study indicates interest for potential combination therapy with chemotherapeutic agents. ROCKVILLE, Md. ...
Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma First development-stage asset to be added to the Essential Pharma portfolio and second product within ...
SAN DIEGO , April 8, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the positive interim analysis results from Phase III clinical study of Cadonilimab (PD-1/CTLA-4 BsAb) combined with XELOX (capecitabine plus ...
– Consistent safety and efficacy profiles across adult and pediatric populations – – Majority of pediatric patients who achieved an overall response proceeded to transplant; patients receiving post-transplant revumenib maintenance ...
Trial has met primary endpoints of safety and immunogenicity and secondary endpoint for efficacy based on response rate Trial data published today in Nature Medicine Selected clinical trial data also presented at the 2024 AACR Annual ...
BETHESDA, Md. , April 5, 2024 PRNewswire/ -- Precision Biologics, Inc. reports its lead monoclonal antibody, NEO-201, targets circulating human naïve regulatory T cells (Tregs) in both healthy donors and cancer patients. A poster ...
ROTTERDAM, Netherlands and SAN DIEGO , April 5, 2024 /PRNewswire/ -- SkylineDx is pleased to announce two forthcoming scientific publications at the European Association for Dermato-Oncology congress, April 4-6, 2024 . These ...
CHEYNEY, Pa. , April 4, 2024 /PRNewswire/ -- Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, will be presenting preclinical data on its next-generation anti-CD20 ...
Data demonstrate that uPARAP is highly expressed in tumor samples obtained from glioblastoma multiforme patients uPARAP targeting ADC shows cytotoxicity in glioblastoma multiforme cancer cells in vitro and exhibits potent in ...
BERLIN , April 4, 2024 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announces that it will be ...
During a recent 2024 Annual meeting of the American Association for Cancer Research (AACR), promising data from a Phase II trial were presented. The outcome of the trial proved the effectiveness of the combination treatment involving Immunogen's ...
India shoulders a substantial burden of oral cancers, accounting for approximately 30% of all global cases. April is Oral Cancer Awareness Month. ( ) Also known as mouth cancer, the disease is the most common form of head and neck ...
Groundbreaking research introduces drug-loaded 3D printed films that could revolutionize cancer treatments. These innovative films, containing tailored doses of anti-cancer drugs 5-fluorouracil (5FU) and cisplatin (Cis), not only eliminate over 80% ...
Patients with locally advanced prostate cancer experience prolonged control of prostate-specific antigen (PSA) levels when treated with a combination of chemotherapy and hormonal therapy, as opposed to hormonal therapy alone ( ). " Our ...
A recent study published in JNCI Cancer Spectrum by Oxford University Press indicates that adopting a healthy diet can reduce the risk of cardiovascular disease among breast cancer survivors ( ). Cardiovascular ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers